BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8402499)

  • 1. Neurofibromatosis type 1 and childhood cancer.
    Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
    Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
    Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
    Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic manifestations in children with neurofibromatosis type 1 in Turkey.
    İncecik F; Altunbaşak Ş; Hergüner MÖ; Bayram İ; Küpeli S; Demirbilek H
    Turk J Pediatr; 2013; 55(3):266-70. PubMed ID: 24217072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
    Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
    Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 and malignancy in childhood.
    Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
    Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.
    Bhatia S; Chen Y; Wong FL; Hageman L; Smith K; Korf B; Cannon A; Leidy DJ; Paz A; Andress JE; Friedman GK; Metrock K; Neglia JP; Arnold M; Turcotte LM; de Blank P; Leisenring W; Armstrong GT; Robison LL; Clapp DW; Shannon K; Nakamura JL; Fisher MJ
    J Clin Oncol; 2019 Nov; 37(32):3050-3058. PubMed ID: 31532722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
    Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
    Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
    Yamauchi T; Suka M; Nishigori C; Yanagisawa H
    Orphanet J Rare Dis; 2019 Jul; 14(1):166. PubMed ID: 31277677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
    Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
    J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
    Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
    JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).
    Gutmann DH; Rasmussen SA; Wolkenstein P; MacCollin MM; Guha A; Inskip PD; North KN; Poyhonen M; Birch PH; Friedman JM
    Neurology; 2002 Sep; 59(5):759-61. PubMed ID: 12221173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
    J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.
    de Blank P; Li N; Fisher MJ; Ullrich NJ; Bhatia S; Yasui Y; Sklar CA; Leisenring W; Howell R; Oeffinger K; Hardy K; Okcu MF; Gibson TM; Robison LL; Armstrong GT; Krull KR
    Genet Med; 2020 Nov; 22(11):1794-1802. PubMed ID: 32572180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.